Formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis

BASF has been committed to the pharmaceutical industry since we introduced our original Kollidon in the early 20th century. Since then we have continuously expanded our solution offer. Today we solve unmet formulation needs and offer intelligent solutions for today and tomorrow's challenges in drug formulation. Our four dedicated solution platforms based on current pharmaceutical market needs help you to find what you are looking for – faster than ever before. Find the answer to your Instant and Modified Release, Solubilization, Skin Delivery and Softgels related formulation challenges.

Formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis

formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis

Media:

formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitisformulation considerations of intranasal corticosteroids for the treatment of allergic rhinitisformulation considerations of intranasal corticosteroids for the treatment of allergic rhinitisformulation considerations of intranasal corticosteroids for the treatment of allergic rhinitisformulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis

http://buy-steroids.org